GENEVA, Aug. 31 -- GUANGZHOU MAGPIE PHARMACEUTICALS CO., LTD. filed a patent application (CN2026/078709) for “USE OF NITRONE COMPOUND IN PREPARATION OF PRODUCT FOR PREVENTING OR TREATING SIDE EFFECTS CAUSED BY ANTI-OBESITY DRUGS”. With publication no. WO/2026/175295, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4965
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....